Perhaps fine-tuned and targeted manipulations of nuclear receptor binding sites within promoters, enhancers and switch sites of the immunoglobulin loci will ultimately prove successful for the control and optimization of immunoglobulin expression. == Abbreviations == == Funding == This study was supported in part by NIH NCI P30CA21765, NIH NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs) contract 75N93019C00052, and ALSAC. a ligand-binding domain name (LBD), and a transactivation domain name [1,2]. Type I receptors (including estrogen receptor (ER), glucocorticoid receptor (GR), progesterone receptor (PR), and androgen receptor (AR)) are typically homodimers, while type II receptors are typically heterodimers. Examples of type II receptors include retinoic acid receptor-retinoid X receptor (RAR-RXR), vitamin D receptor-RXR (VDR-RXR) and thyroid receptor-RXR (TR-RXR). Multiple isoforms exist for the protein subunits. RXR proteins, for example, include RXR, RXR, and RXR, each associated with different binding patterns and functions [1,3]. RAR proteins include RAR, RAR, and RAR. Ligands for the nuclear receptors, both natural and synthetic, are numerous. Examples include vitamin A metabolites (for RAR, RXR, and the peroxisome proliferator-activated receptor / (PPAR /) [4]), 17- estradiol (for ER), progesterone (for PR), testosterone and dihydrotestosterone (for AR), 3,3,5,5 triiodo-L-thyroxine (for the thyroid receptor [TR]), and dexamethasone and prednisolone (for GR). The natural ligand for RXR remains a topic of argument. Although 9-cis retinoic acid has been discovered to bind RXR, this metabolite is usually difficult to detect in many mammalian tissues. Other possible natural ligands for RXR include unsaturated fatty acids such as docosahexaenoic acid, arachidonic acid and oleic acid [3]. The influences of nuclear receptors and their ligands around the mammalian cell are extraordinarily complex. Vitamin A, for example, signals the mammalian cell as soon as it reaches the plasma membrane [5]. CD3G Signals continue as vitamin traffics through the cell toward the nucleus, engaging numerous chaperones along the way. Receptors such as RXR also exhibit cytoplasmic functions, distinct from their activities as transcription factors. Within the nucleus, when vitamin A serves as a ligand for its nuclear receptors, it can instruct conformational changes [1,6,7,8,9]. Ligand-bound and unbound receptors, when associated with DNA (either by direct DNAprotein interactions or by DNA tethering via proteinprotein interactions), can recruit, inhibit, and interact with other transcription factors to instruct DNA configurations and gene expression patterns [1]. Class II heterodimers have been further characterized as permissive or non-permissive. The term permissive was attributed to heterodimers that were activated in a controlled establishing by ligand binding either to RXR, its partner protein (e.g., PPAR), or both. Indeglitazar The term nonpermissive was attributed to heterodimers that could not be activated by ligand binding to RXR alone. Permissive receptor proteins include PPAR, liver X receptor (LXR), farnesoid X receptor (FXR), pregnane X receptor (PXR) and constitutive androstane receptor (CAR), each of which is responsive to diet-derived lipids. Non-permissive receptor proteins include RAR, VDR, and TR [1,10,11,12]. A survey of nuclear receptor DNA-binding patterns has revealed consensus nucleotide motifs (response elements) to which each receptor preferentially binds. As examples, type II receptors often bind two Indeglitazar tandem, hexad half-sites, RG(G/T)TCA, separated by a short spacer [13]. RAR-RXR binding to DNA shows a preference for spacers of size 5 (direct repeat 5, DR5) or 2 (DR2), whereas VDR-RXR binding to DNA shows a preference for spacers of size 3 (DR3) and TR-RXR shows a preference for spacers of size 4 (DR4) [1]. Occasionally, the receptors bind individual half-sites or half-sites separated by unusually long spacers. RXR can also function as a self-sufficient homodimer, able to bind a DR1 element. The estrogen receptor often binds a palindromic motif GGTCAnnnTGACC [14,15]. These binding patterns are far from complete and binding is usually often observed at sites that lack a canonical sequence [1,7,9,16,17,18,19,20,21,22,23,24,25,26,27,28,29]. Nuclear receptor cross-regulation is usually supported by receptor sharing of (i) protein partners (RXR is usually shared among the type II receptors), (ii) ligands (e.g., retinol binds RAR-RXR and PPAR-RXR), and (iii) DNA binding sites. The outcome of nuclear receptor binding to DNA is usually difficult to predict due to the high complexity of proteinDNA complexes. For example, the estrogen regulation of theGREB1gene entails ER and RNA polymerase II (RNA Pol II) binding to three different estrogen response elements (ERE) within a 20 kb region and DNA looping that associates EREs with the genes transcriptional start site [30,31]. == 2. Antibody Expression by the Mature B Cell == In the developing fetus, the site of mammalian B cell development is the yolk sac. Post-birth, standard B cells develop in the bone marrow, dependent on bone marrow stroma. Stem cells progress through multiple stages of B cell development. At the pro B cell stage, gene rearrangements are initiated in the immunoglobulin heavy chain locus. Each B cell undergoes unique D-J and V-DJ gene Indeglitazar rearrangements with the excision of intervening sequences to create a V-D-J coding sequence. At the pre-B cell stage, the transcription of V-D-J-C mRNA sequences and RNA splicing yield a heavy chain protein that can.